Welcome to our dedicated page for Sensient Tech SEC filings (Ticker: SXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Sensient Technologies Corporation (NYSE: SXT), a global manufacturer and marketer of colors, flavors, and other specialty ingredients. Through these filings, investors can review the company’s official disclosures about its operations, financing arrangements, governance, and financial results.
Sensient’s SEC submissions include Form 8-K current reports that describe material events. Recent 8-K filings have covered topics such as quarterly earnings press releases and accompanying investor presentations, amendments to the company’s Amended and Restated By-Laws, leadership changes in the Color Group and Flavors & Extracts Group, and updates to credit facilities and receivables securitization programs. These documents offer timely insight into segment performance, capital structure, and corporate governance decisions.
In addition to current reports, investors typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed financial statements, segment information for the Flavors & Extracts, Color, and Asia Pacific groups, and discussions of risk factors and accounting policies. While those specific forms are not reproduced in the text above, they are part of Sensient’s regular reporting cycle and can be accessed through this filings feed.
Stock Titan enhances these regulatory documents with AI-powered summaries that highlight key points, such as changes in segment results, updates to credit agreements, or amendments to governance documents. Real-time integration with the SEC’s EDGAR system helps surface new filings as they become available, while structured views of items like 8-K exhibits and financing agreements make it easier to locate information on revolving credit facilities, receivables securitization programs, and related covenants.
For users interested in executive transitions, board actions, or committee changes, Item 5.02 and Item 5.03 disclosures in Sensient’s 8-K filings provide additional detail. For those focused on capital and liquidity, Items 1.01 and 2.03 filings describe material definitive agreements and direct financial obligations. By combining these documents with AI-generated explanations, this page helps investors interpret Sensient Technologies Corporation’s regulatory history and understand how specific filings relate to the SXT investment thesis.
Sensient Technologies director Donald W. Landry reported routine equity compensation activity. He received a grant of 1,119 shares of restricted common stock under the company’s 2017 Stock Plan and had 674 shares withheld to cover tax obligations upon vesting of a prior restricted stock grant.
After these transactions, he directly holds 11,121.331 shares of common stock, including restricted shares under the 2017 Stock Plan and shares held in a dividend reinvestment plan. The filing shows compensation- and tax-related movements rather than open-market buying or selling.
Sensient Technologies Corp director Brett W. Bruggeman reported routine equity compensation and related tax withholding. He received a grant of 1,119 shares of Common Stock as restricted stock under the company’s 2017 Stock Plan, as amended and restated.
In connection with the vesting of a prior restricted stock grant, 283 shares of Common Stock were withheld to cover tax obligations at an indicated price of $99.23 per share. After these transactions, he directly holds 3,848.542 shares of Sensient common stock, including restricted shares and shares in a dividend reinvestment plan.
Sensient Technologies director Joseph Carleone reported an equity compensation grant and updated holdings. On April 23, 2026, he received 1,119 shares of Common Stock as a grant of restricted stock under the issuer’s 2017 Stock Plan at a stated price of $0.0000 per share.
After this award, Carleone directly owns 23,670.313 shares of Common Stock, which include restricted shares and shares in a dividend reinvestment plan. He also holds Deferred Stock linked to 23,780.400 underlying shares of Common Stock, which convert one-for-one and will be issued when his board service ends.
Sensient Technologies director Mario Ferruzzi reported routine equity compensation and related tax withholding. On April 23, 2026, he received 1,119 shares of common stock as a restricted stock grant under the company’s 2017 Stock Plan, increasing his directly held common shares to 9,195.186, which include restricted stock and dividend reinvestment plan shares. On the same date, 674 common shares were withheld at $99.23 per share to cover tax obligations from a prior restricted stock vesting, a non-market disposition.
Ferruzzi also reports 227.665 common shares held indirectly through his spouse’s ESOP account and 3,322.810 deferred stock units that convert to common stock on a one-for-one basis, with shares to be issued when his service as a director ends.
Sensient Technologies director Carol R. Jackson reported compensation-related stock transactions involving company common stock. On April 23, 2026, she received a grant of 1,119 shares of restricted stock under Sensient's 2017 Stock Plan, as amended and restated.
On the same date, 674 shares were withheld to cover tax obligations tied to the vesting of a prior restricted stock grant, a non‑market, tax-withholding disposition. After these entries, Jackson directly held 7,213.958 shares, including restricted stock and shares in a dividend reinvestment plan.
Jain Sharad P reported acquisition or exercise transactions in this Form 4 filing.
Sensient Technologies director Sharad P. Jain received 1,119 shares of common stock as a restricted stock grant under the company’s 2017 Stock Plan. This award was made at no cash cost to Jain and increased his direct holdings to 6,997.266 shares, including restricted shares and dividend reinvestment plan shares.
Sensient Technologies director Scott C. Morrison reported routine equity compensation activity. He received a grant of 1,119 shares of common stock as restricted stock under the company’s 2017 Stock Plan at no cash cost. In a separate move, 674 shares were withheld to cover tax obligations tied to the vesting of an earlier restricted stock grant, which is not an open-market sale. After these transactions, he directly holds about 12,220 shares of Sensient common stock, including restricted shares and shares held in a dividend reinvestment plan.
Sensient Technologies director Essie Whitelaw reported routine equity compensation activity. She received a grant of 1,119 shares of Common Stock as restricted stock under the company’s 2017 Stock Plan, at a stated price of $0.0000 per share. In connection with the vesting of a prior restricted stock grant, 674 shares of Common Stock were withheld at $99.23 per share to cover tax obligations rather than sold on the open market. After these transactions, she directly holds 18,258.136 shares of Common Stock, which include restricted shares and shares in a dividend reinvestment plan. She also holds deferred stock convertible into 885.666 Common Stock shares on a one-for-one basis, to be issued when her board service ends.
Sensient Technologies reported a strong start to 2026, with first quarter revenue rising to $435.8 million, up 11.1% from $392.3 million a year earlier. Operating income increased to $66.7 million, a 24.7% gain, as margins improved.
Net earnings grew to $44.2 million, and diluted EPS rose to $1.04 from $0.81. All three segments—Flavors & Extracts, Color, and Asia Pacific—delivered revenue and operating income growth, led by particularly strong performance in Color.
Management highlighted momentum in natural colors and raised full-year 2026 guidance. The company now targets local currency revenue and adjusted EBITDA growth in the high single to double digits, and increased GAAP EPS guidance to a range of $3.70–$3.90.
Sensient Technologies director Joseph Carleone received 422.547 shares of deferred stock as a grant tied to director fee deferrals. This deferred stock converts into common stock on a one-for-one basis and is issued after his service as a director ends.
Following the grant, his reported deferred stock holdings total 23,780.400 shares. A separate holding entry shows 22,551.313 shares of common stock held directly, which includes restricted stock under the company’s 2017 Stock Plan and shares accumulated through a dividend reinvestment plan.